全文获取类型
收费全文 | 12993篇 |
免费 | 523篇 |
国内免费 | 353篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 124篇 |
妇产科学 | 24篇 |
基础医学 | 393篇 |
口腔科学 | 9篇 |
临床医学 | 1159篇 |
内科学 | 2777篇 |
皮肤病学 | 11篇 |
神经病学 | 163篇 |
特种医学 | 242篇 |
外国民族医学 | 1篇 |
外科学 | 5857篇 |
综合类 | 2198篇 |
预防医学 | 275篇 |
眼科学 | 23篇 |
药学 | 480篇 |
1篇 | |
中国医学 | 81篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 7篇 |
2023年 | 155篇 |
2022年 | 215篇 |
2021年 | 497篇 |
2020年 | 411篇 |
2019年 | 424篇 |
2018年 | 464篇 |
2017年 | 295篇 |
2016年 | 249篇 |
2015年 | 322篇 |
2014年 | 828篇 |
2013年 | 748篇 |
2012年 | 559篇 |
2011年 | 730篇 |
2010年 | 605篇 |
2009年 | 787篇 |
2008年 | 754篇 |
2007年 | 785篇 |
2006年 | 689篇 |
2005年 | 634篇 |
2004年 | 534篇 |
2003年 | 449篇 |
2002年 | 332篇 |
2001年 | 340篇 |
2000年 | 264篇 |
1999年 | 253篇 |
1998年 | 213篇 |
1997年 | 224篇 |
1996年 | 153篇 |
1995年 | 138篇 |
1994年 | 94篇 |
1993年 | 92篇 |
1992年 | 97篇 |
1991年 | 78篇 |
1990年 | 54篇 |
1989年 | 53篇 |
1988年 | 40篇 |
1987年 | 43篇 |
1986年 | 42篇 |
1985年 | 37篇 |
1984年 | 34篇 |
1983年 | 16篇 |
1982年 | 37篇 |
1981年 | 16篇 |
1980年 | 23篇 |
1979年 | 15篇 |
1978年 | 17篇 |
1977年 | 9篇 |
1974年 | 5篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
11.
Changes in Right Ventricular Shape and Deformation Following Coronary Artery Bypass Surgery—Insights from Echocardiography with Strain Rate and Magnetic Resonance Imaging 下载免费PDF全文
12.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献13.
J.A. Hannam S.J. Mitchell D. Cumin C. Frampton A.F. Merry M.R. Moore C.J. Kruger 《British journal of anaesthesia》2019,122(2):198-205
Background
Etomidate is frequently selected over propofol for induction of anaesthesia because of a putatively favourable haemodynamic profile, but data confirming this perception are limited.Methods
Patients undergoing cardiac surgery were randomised to induction of anaesthesia with propofol or etomidate. Phase I (n=75) was conducted as open-label, whereas Phase II (n=75) was double blind. Mean arterial blood pressure (MAP) and boluses of vasopressor administered after induction were recorded. The primary endpoint was the area under the curve below baseline MAP (MAP-time integral) during the 10 min after induction. Secondary endpoints were the use of vasopressors over the same period, and the effect of blinding on the aforementioned endpoints. Groups were compared using regression models with phase and anaesthetist as factors.Results
The mean difference between etomidate and propofol in the MAP-time integral below baseline was 2244 mm Hg s (95% confidence interval, 581–3906; P=0.009), representing a 34% greater reduction with propofol. Overall, vasopressors were used in 10/75 patients in the etomidate group vs 21/75 in the propofol group (P=0.38), and in 20/74 patients during the blinded phase vs 11/76 during the open-label phase (P=0.31). The interaction between randomisation and phase (open-labelled or blinded) was not significant for either primary (P=0.73) or secondary endpoints (P=0.90).Conclusions
Propofol caused a 34% greater reduction in MAP-time integral from baseline after induction of anaesthesia than etomidate, despite more frequent use of vasopressors with propofol, confirming the superior haemodynamic profile of etomidate in this context. The proportion of patients receiving vasopressors increased slightly, albeit not significantly, in both groups in the blinded phase.Clinical trial registration
Australian and New Zealand Clinical Trials Registry, ACTRN12614000717651. 相似文献14.
Joshua Manghelli Lisa Brown Hany B. Tadros Nabil A. Munfakh 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(5):491-494
The inflammatory response induced by cardiopulmonary bypass decreases vascular tone, which in turn can lead to vasoplegic syndrome. Indeed the hypotension consequent to on-pump cardiac surgery often necessitates vasopressor and intravenous fluid support. Methylene blue counteracts vasoplegic syndrome by inhibiting the formation of nitric oxide.We report the use of methylene blue in a 75-year-old man who developed vasoplegic syndrome after cardiac surgery. After the administration of methylene blue, his hypotension improved to the extent that he could be weaned from vasopressors. The use of methylene blue should be considered in patients who develop hypotension refractory to standard treatment after cardiac surgery. 相似文献
15.
16.
Benjamin R. Griffin J. Pedro Teixeira Sophia Ambruso Michael Bronsert Jay D. Pal Joseph C. Cleveland T. Brett Reece David A. Fullerton Sarah Faubel Muhammad Aftab 《The Journal of thoracic and cardiovascular surgery》2021,161(4):1346-1355.e3
ObjectivesSevere acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality.MethodsIn this retrospective propensity score–matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS).ResultsStage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71–3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45).ConclusionsStage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity. 相似文献
17.
Anand Dayama Nikolaos Tsilimparis Stephen Kolakowski Nathaniel M. Matolo Misty D. Humphries 《Journal of vascular surgery》2019,69(1):156-163.e1
Background
Chronic limb-threatening ischemia (CLTI), defined as ischemic rest pain or tissue loss secondary to arterial insufficiency, is caused by multilevel arterial disease with frequent, severe infrageniculate disease. The rise in CLTI is in part the result of increasing worldwide prevalence of diabetes, renal insufficiency, and advanced aging of the population. The aim of this study was to compare a bypass-first with an endovascular-first revascularization strategy in patients with CLTI due to infrageniculate arterial disease.Methods
We reviewed the American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity revascularization database from 2012 to 2015 to identify patients with CLTI and isolated infrageniculate arterial disease who underwent primary infrageniculate bypass or endovascular intervention. We excluded patients with a history of ipsilateral revascularization and proximal interventions. The end points were major adverse limb event (MALE), major adverse cardiovascular event (MACE), amputation at 30 days, reintervention, patency, and mortality. Multivariable logistic regression was used to determine the association of a bypass-first or an endovascular-first intervention with outcomes.Results
There were 1355 CLTI patients undergoing first-time revascularization to the infrageniculate arteries (821 endovascular-first revascularizations and 534 bypass-first revascularizations) identified. There was no significant difference in adjusted rate of 30-day MALE in the bypass-first vs endovascular-first revascularization cohort (9% vs 11.2%; odds ratio [OR], 0.73; 95% confidence interval [CI], 0.50-1.08). However, the incidence of transtibial or proximal amputation was lower in the bypass-first cohort (4.3% vs 7.4%; OR, 0.60; CI, 0.36-0.98). Patients with bypass-first revascularization had higher wound complication rates (9.7% vs 3.7%; OR, 2.75; CI, 1.71-4.42) compared with patients in the endovascular-first cohort. Compared with the endovascular-first cohort, the incidence of 30-day MACE was significantly higher in bypass-first patients (6.9% vs 2.6%; adjusted OR, 3.88; CI, 2.18-6.88), and 30-day mortality rates were 3.23% vs 1.8% (adjusted OR, 2.77; CI, 1.26-6.11). There was no difference in 30-day untreated loss of patency, reintervention of treated arterial segment, readmissions, and reoperations between the two cohorts. In subgroup analysis after exclusion of dialysis patients, there was also no significant difference in MALE or amputation between the bypass-first and endovascular-first cohorts.Conclusions
CLTI patients with isolated infrageniculate arterial disease treated by a bypass-first approach have a significantly lower 30-day amputation. However, this benefit was not observed when dialysis patients were excluded. The bypass-first cohort had a higher incidence of MACE compared with an endovascular-first strategy. These results reaffirm the need for randomized controlled trials, such as the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL-2) trial and Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), to provide level 1 evidence for the role of endovascular-first vs bypass-first revascularization strategies in the treatment of this population of challenging patients. 相似文献18.
目的研究非体外循环冠状动脉旁路移植术(OPCAB)后造血干细胞动员的规律及影响因素。方法对55例择期行OPCAB、近期无急性心肌梗死患者,分别于术前30m in、术后6、12、24、48、72和120h采外周静脉血4m l,CD 34和CD 45双抗标记、流式细胞仪检测造血干细胞计数,同时检测心肌酶谱及肌钙蛋白T的变化。结果冠心病患者术前造血干细胞计数占外周血有核细胞数计数的0.13%±0.12%,OPCAB后明显升高,24h达到峰值(0.34%±0.20%),术后120h回到术前基线水平;吸烟、高血脂、糖尿病对造血干细胞动员无明显影响,但合并高血压病患者外周血造血干细胞动员明显低于无高血压病患者;术后24h造血干细胞动员与肌酸激酶及肌酸激酶同工酶、乳酸脱氢酶、肌钙蛋白T呈正相关(r=0.692,P=0.000;r=0.558,P=0.000;r=0.447,P=0.000;r=0.401,P=0.004)。结论OPCAB术后造血干细胞快速、短暂动员,心肌损伤程度、冠心病危险因素参与了造血干细胞动员的调节。 相似文献
19.
心肺转流时间对氧代谢的影响 总被引:1,自引:1,他引:0
目的对心脏瓣膜手术病人麻醉与手术期间的氧代谢进行测定,探讨心肺转流(CPB)时间对其后氧代谢的影响。方法选择36例择期行心脏瓣膜手术病人,根据CPB时间,将病人分为S组(CPB≤150 min)和L组(CPB>150 min)。采用Swan-Ganz导管技术及反向Fick检测方法对麻醉手术期间的氧代谢进行测定。检测时点为麻醉前、CPB前、CPB停止10 min和60 min。结果麻醉前两组的pH、PaCO2、PaO2等血气参数维持在正常范围,但氧供(DO2)减少,氧摄取率(O2ER)增加。CPB前,两组病人DO2显著降低(P<0.05),S组的氧耗(VO2)显著降低(P<0.05)。CPB后10min到60 min期间,DO2、VO2显著增加(P<0.05),L组O2ER显著增加(P<0.05)。CPB后10 min和60 min,两组的pH、PaCO2及PaO2等虽与麻醉前比较有显著改变,但两组的变化是一致的。CPB后10 min两组的心指数(CI)较麻醉前和CPB前有极显著升高(P<0.01)。CPB后L组的VO2有增高趋势(P<0.05),O2ER明显大于S组。结论CPB对其后氧代谢有明显影响,随着CPB时间延长,CPB后氧代谢障碍更显著。 相似文献
20.
Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery 总被引:5,自引:0,他引:5
Arthur M. Carlin M.D. D. Sudhaker Rao MB B.S. F.A.C.P. F.A.C.E. Ali M. Meslemani M.D. Jeffrey A. Genaw M.D. Nayana J. Parikh Shiri Levy M.D. Arti Bhan M.D. Gary B. Talpos M.D. 《Surgery for obesity and related diseases》2006,2(2):696-103
BACKGROUND: Abnormalities in calcium and vitamin D metabolism have been reported after bariatric surgery. The purpose of this study was to evaluate vitamin D nutritional status among morbidly obese patients before gastric bypass surgery. METHODS: We prospectively studied 279 morbidly obese patients seeking gastric bypass surgery for vitamin D nutritional status as assessed by serum 25-hydroxyvitamin D level. In addition, serum samples were analyzed for calcium, alkaline phosphatase (AP), intact parathyroid hormone (PTH), and 1,25-dihydroxyvitamin D. RESULTS: Mean patient age was 43 +/- 9 years; 87% of the study patients were women, and 72% were white. Serum calcium and AP levels were normal in 88% and 89% of the patients, respectively. Vitamin D depletion, defined as serum 25-hydroxyvitamin D level bypass surgery, a majority of morbidly obese patients have vitamin D depletion and secondary hyperparathyroidism. Studies evaluating the effects of gastric bypass on vitamin D metabolism must consider preoperative vitamin D nutritional status. 相似文献